1. Acknowledgment

   Acknowledgment 13 September 2012 Pages: 343 - 344

2. Angiotensin Antagonism in Patients with Heart Failure

   • Nicholas L. M. Cruden
   • David E. Newby

   Current Opinion 13 September 2012 Pages: 345 - 353

   

3. Paclitaxel-Eluting Stents

   • Eberhard Grube
   • Lutz Buellesfeld

   Leading Article 13 September 2012 Pages: 355 - 360

   

4. Therapeutic Effects of Angiotensin (AT₁) Receptor Antagonists

   • Boris Schmidt
   • Helmut Drexler
   • Bernhard Schieffer

   Review Article 13 September 2012 Pages: 361 - 368

   

5. Reversal of Left Ventricular Hypertrophy

   • Paolo Verdecchia
   • Fabio Angeli

   Review Article 13 September 2012 Pages: 369 - 378

   

6. Clinical and Experimental Experience with Factor Xa Inhibitors

   • Juan F. Viles-Gonzalez
   • Juan Gaztanaga
   • Juan J. Badimon

   Review Article 13 September 2012 Pages: 379 - 384

   

7. Intravascular Brachytherapy

   • Balram Bhargava
   • Ganesan Karthikeyan
   • Prabhakar Tripuraneni

   Review Article 13 September 2012 Pages: 385 - 394

   

8. Valsartan

   • Katherine F. Croom
   • Gillian M. Keating

   Adis Drug Evaluation 13 September 2012 Pages: 395 - 404

   

9. Ezetimibe/Simvastatin

   • David Murdoch
   • Lesley J. Scott

   Adis Drug Evaluation 13 September 2012 Pages: 405 - 422

   

10. Cardiac Syndrome X: Diagnosis, Pathogenesis and Management

    • A. Dominguez-Rodriguez
    • M. Garcia-Gonzalez
    • P. Abreu-Gonzalez

    Correspondence 13 September 2012 Pages: 423 - 423

11. The Author’s Reply

    • Juan Carlos Kaski

    Correspondence 13 September 2012 Pages: 423 - 423